In short
Sleep problems in women are frequently attributed to hormones alone and treated accordingly. The clinical reality is layered: hormonal transitions change sleep architecture and thermoregulation, while caregiving, schedule fragmentation, and under-recognized sleep apnea change sleep opportunity. CBT-I remains first-line at every life stage, including pregnancy and menopause, where medication options are most constrained.
Why sex differences matter clinically
The insomnia risk difference between women and men is one of the most consistent findings in sleep epidemiology, and it emerges after puberty rather than before it. Several mechanisms contribute: cyclical hormonal variation, higher prevalence of depression and anxiety, disproportionate caregiving and night-waking responsibility, and — importantly — different presentation of sleep apnea.
Obstructive sleep apnea in women more often presents as insomnia, fatigue, morning headache, and mood symptoms rather than loud snoring and witnessed apneas. This drives systematic underdiagnosis. Any woman with persistent unrefreshing sleep deserves genuine consideration of sleep-disordered breathing rather than a reflexive attribution to stress or hormones.
The menstrual cycle
Sleep disruption clusters in the late luteal phase and the first days of menstruation. Progesterone and its metabolites influence sleep continuity, core body temperature rises post-ovulation and shifts the thermal environment for sleep onset, and premenstrual mood symptoms add cognitive arousal.
Women with premenstrual dysphoric disorder report substantially more severe cyclical sleep disruption. The practical clinical step is simple and frequently skipped: track sleep alongside cycle phase. A pattern that repeats monthly requires a different plan than continuous insomnia, and it prevents a predictable few nights from being interpreted as treatment failure.
Pregnancy
Sleep changes in every trimester. Early pregnancy brings increased sleep need alongside nausea and nocturia. The second trimester is typically the most stable. The third brings physical discomfort, reflux, restless legs (frequently iron-related and worth testing), increased nocturia, and rising rates of snoring and sleep-disordered breathing.
Insomnia in pregnancy is common and is not benign — it is associated with perinatal depression and adverse outcomes. Because pharmacological options are limited, CBT-I is the preferred treatment, and randomized trials support its efficacy in prenatal populations. Protocols are adapted: sleep restriction is applied conservatively or not at all, with emphasis on stimulus control, cognitive work, and circadian anchoring. New or worsening snoring, witnessed apneas, or morning headaches warrant evaluation for sleep apnea given associations with gestational hypertension and diabetes.
Postpartum
Postpartum sleep involves genuine, unavoidable fragmentation — but two distinct problems are routinely conflated. Insufficient sleep opportunity from infant care is a logistics problem: it is solved by protected sleep windows, shared night duty, and realistic expectations. Insomnia is being unable to sleep when the opportunity exists, and it requires treatment.
The second is the clinically urgent one. A parent who lies awake anxious while the baby sleeps is describing insomnia, and it is bidirectionally linked with postpartum depression — disrupted sleep raises depression risk, and depression disrupts sleep further. Screening for both together should be routine. CBT-I adapted for postpartum context, with realistic targets and attention to the partner system, is effective.
Perimenopause and menopause
Sleep complaints rise sharply during the menopausal transition, affecting a substantial majority of women. The mechanisms include vasomotor symptoms (hot flashes and night sweats producing awakenings, often preceding conscious awareness of the flash), declining estrogen and progesterone, increased mood symptom risk, and a genuine rise in sleep apnea prevalence after menopause.
Menopausal insomnia is frequently treated only with hormone therapy or hypnotics. Evidence supports CBT-I here specifically: it improves insomnia severity in menopausal women including those with continuing vasomotor symptoms. The most effective approach is usually combined — address hot flashes medically where appropriate, keep the sleep environment cool, treat any sleep apnea, and use CBT-I for the conditioned insomnia that has developed on top of the awakenings and typically persists after the flashes settle.
Later adulthood
Circadian phase advances with age, sleep becomes lighter and more fragmented, and daytime napping increases. Some of this is normal. What is not normal — and is too often accepted as inevitable — is significant insomnia, unrefreshing sleep, and daytime dysfunction.
Older women face additional risks: higher use of medications that disrupt sleep, higher rates of chronic pain, and elevated hazard from hypnotics, which carry falls and cognitive risk in this population. CBT-I is well established in older adults and is the safer first-line option.
Caregiving and cumulative load
Sleep is not only physiological. Women disproportionately carry night-waking responsibility for children and elder care, and this is often invisible in clinical assessment because no one asks. A treatment plan that assumes an eight-hour uninterrupted sleep opportunity that does not exist will fail, and the patient will interpret the failure as personal.
Good behavioral treatment asks about the actual structure of the household night, and where appropriate treats the redistribution of night duty as a legitimate clinical intervention.
Treatment considerations
- CBT-I is first-line at every life stage, and is particularly valuable where medication is contraindicated or undesirable.
- Screen for sleep apnea using female presentation patterns — insomnia, fatigue, and mood rather than classic snoring.
- Screen for mood and anxiety disorders, especially perinatally and perimenopausally, and treat them concurrently.
- Check iron studies where restless legs symptoms are present, especially in pregnancy and with heavy menstrual bleeding.
- Adapt protocols rather than abandoning them. Sleep restriction may be modified in pregnancy and postpartum; stimulus control and cognitive therapy remain fully available.
- Coordinate care. Obstetric, primary care, menopause, and behavioral sleep treatment should be aligned rather than sequential.
Clinical care at Sleep & Change includes CBT-I adapted for perinatal and menopausal contexts, with coordination alongside existing medical providers.
References
- Zhang B, Wing YK. Sex differences in insomnia: a meta-analysis. Sleep. 2006;29(1):85-93.
- Baker FC, Lee KA. Menstrual cycle effects on sleep. Sleep Medicine Clinics. 2018;13(3):283-294.
- Manber R, et al. Cognitive behavioral therapy for prenatal insomnia: a randomized controlled trial. Obstetrics & Gynecology. 2019;133(5):911-919.
- Baker FC, et al. Sleep and sleep disorders in the menopausal transition. Sleep Medicine Clinics. 2018;13(3):443-456.
Written and reviewed by Christine Mason, PhD, DBSM, health psychologist board-certified in behavioral sleep medicine. Published August 25, 2026. Last reviewed August 25, 2026.
